Skip to content
← Back to this collection

PUBLICATIONS · 39197072

Ide-cel vs standard regimens in triple-class-exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2024 Dec 5
First author
Ailawadhi S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Ailawadhi S
      type
      Author
    2. name
      Arnulf B
      type
      Author
    3. name
      Patel K
      type
      Author
    4. name
      Cavo M
      type
      Author
    5. name
      Nooka AK
      type
      Author
    6. name
      Manier S
      type
      Author
    7. name
      Callander N
      type
      Author
    8. name
      Costa LJ
      type
      Author
    9. name
      Vij R
      type
      Author
    10. name
      Bahlis NJ
      type
      Author
    11. name
      Moreau P
      type
      Author
    12. name
      Solomon S
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Ailawadhi S
      type
      Author
    2. name
      Arnulf B
      type
      Author
    3. name
      Patel K
      type
      Author
    4. name
      Cavo M
      type
      Author
    5. name
      Nooka AK
      type
      Author
    6. name
      Manier S
      type
      Author
    7. name
      Callander N
      type
      Author
    8. name
      Costa LJ
      type
      Author
    9. name
      Vij R
      type
      Author
    10. name
      Bahlis NJ
      type
      Author
    11. name
      Moreau P
      type
      Author
    12. name
      Solomon S
      type
      Author
    bibliography ids
    1. nci-bib-feeb963cf6d9affaabcd5027
    book metadata
    content sha256
    2b88b706131e61c5af2e8fa8360edb2728006ff32cdb25db78c95540d3536656
    document type
    citation
    dois
    1. 10.1182/blood.2024024582
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:39197072
    immutable id
    pubmed:39197072@2b88b706131e61c5af2e8fa8360edb2728006ff32cdb25db78c95540d3536656
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    23
    name
    Blood
    nlm unique id
    7603509
    pages
    2389-2401
    volume
    144
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      39197072
      provenance
      batch id
      3e43afde6f26fc8df6da
      provider
      NCBI PubMed ESummary
      record sha256
      30f57d8ab2b7b339701e8da6277228f5da60daab53573683e6feff61dc3f7dfb
      response sha256
      fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
      retrieved at
      2026-09-09T23:48:21.145285+00:00
      publication date
      display
      2024 Dec 5
      precision
      day
      year
      2024
      publication types
      1. Journal Article
      2. Clinical Trial, Phase III
      3. Randomized Controlled Trial
      4. Multicenter Study
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/39197072/
      title
      Ide-cel vs standard regimens in triple-class-exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses.

      Preserved source evidence · Not medical advice